Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060361) titled 'Pulsed Field Ablation for Atrial Fibrillation Improves Right Ventricular Pulmonary Artery Coupling Without Increasing in Pulmonary Artery Pressure' on Sept. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Toyama Prefectural Central Hospital
Condition:
Condition - Atrial Fibrillation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study was to investigate the impact of PFA for AF on RV PA coupling, as assessed by the echocardiographic ratio of TAPSE to PASP, between baseline and 3 months follow-up.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - We analyzed consecutive patients with AF who were referred to the Toyama Prefectural Central Hospital in Japan between April 2025 and September 2025 and underwent catheter ablation using PFA systems.
Key exclusion criteria - Patients with mild tricuspid regurgitation(TR) in whom a clear TR Doppler envelope could not be obtained were excluded. Patients lacking either inspiratory/expiratory phases of inferior vena cava diameters were also excluded.
Target Size - 100
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2025 Year 12 Month 01 Day
Date of IRB - 2026 Year 01 Month 05 Day
Anticipated trial start date - 2025 Year 12 Month 30 Day
Last follow-up date - 2025 Year 12 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068905
Disclaimer: Curated by HT Syndication.
